Skip to main content
Carmot Therapeutics Inc. (CRMO)
Carmot Therapeutics was planning to go public, but the IPO was withdrawn on Dec 11, 2023.
Stock Price: Pending
IPO price not available yet

Carmot Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
-38.8325.37
Depreciation & Amortization
0.640.51
Share-Based Compensation
0.860.63
Other Operating Activities
-0.57-50.06
Operating Cash Flow
-37.91-23.56
Capital Expenditures
-1.54-1.1
Change in Investments
-88.218.01
Investing Cash Flow
-89.766.9
Share Issuance / Repurchase
13.470.3
Debt Issued / Paid
-30
Other Financing Activities
116.85-
Financing Cash Flow
130.3230.3
Net Cash Flow
2.6513.64
Free Cash Flow
-39.45-24.66
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).